AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pattison, D. J
Right arrow Articles by Silman, A. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pattison, D. J
Right arrow Articles by Silman, A. J
Agricola
Right arrow Articles by Pattison, D. J
Right arrow Articles by Silman, A. J
American Journal of Clinical Nutrition, Vol. 82, No. 2, 451-455, August 2005
© 2005 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Dietary ß-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective study1,2,3

Dorothy J Pattison, Deborah PM Symmons, Mark Lunt, Ailsa Welch, Sheila A Bingham, Nicholas E Day and Alan J Silman

1 From the Arthritis Research Campaign Epidemiology Unit, The University of Manchester, Manchester, United Kingdom (DJP, DPMS, ML, and AJS), and the Department of Public Health and Primary Care, the Institute of Public Health, the University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom (AW, SAB, and NED)

Background: Epidemiologic studies suggest that the antioxidant potential of dietary carotenoids may protect against the oxidative damage that can result in inflammation.

Objective: We investigated the hypothesis that some dietary carotenoids are associated with a reduced risk of developing inflammatory polyarthritis (IP).

Design: The European Prospective Investigation of Cancer Incidence (EPIC)-Norfolk study is a population-based, prospective study of >25000 subjects who completed a baseline 7-d diet diary and were followed up to identify new cases of IP, which was defined as synovitis that affected ≥2 joint groups. Dietary carotenoid intakes were computed from the diet diaries of these subjects, and a nested, case-control analysis was undertaken to compare carotenoid intake between case subjects and age- and sex-matched control subjects.

Results: Eighty-eight incident cases of IP that occurred in the population surveyed were ascertained via the Norfolk Arthritis Register. The mean daily intakes of zeaxanthin and ß-cryptoxanthin were 20% and 40% lower, respectively, in the cases than in the 176 controls, but there were no significant differences in the intakes of either lutein or lycopene. Those subjects in the top one-third of intake of zeaxanthin and ß-cryptoxanthin were at a lower risk of developing IP than were subjects in the lowest one-third [odds ratios (95% CI): 0.48 (0.24, 0.94) and 0.51 (0.25, 1.02) for zeaxanthin and ß-cryptoxanthin, respectively]. The association with ß-cryptoxanthin was significant after adjustments were made for total energy and protein intakes and for cigarette smoking.

Conclusion: These data are consistent with previous evidence showing that a modest increase in ß-cryptoxanthin intake, equivalent to one glass of freshly squeezed orange juice per day, is associated with a reduced risk of developing inflammatory disorders such as rheumatoid arthritis.

Key Words: Prospective study • dietary ß-cryptoxanthin • antioxidant • inflammatory polyarthritis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society for Nutrition